Publications

All our publications

*Listed are the articles found in the PubMed database.

Publications by “Agueda González Rodríguez”

Assessment of skeletal muscle alterations and circulating myokines in metabolic dysfunction-associated steatotic liver disease: A cross-sectional study.

Real Martinez, Y, Fernandez-Garcia, CE, Fuertes-Yebra, E, Calvo Soto, M, Berlana, A, Barrios, V, Caldas, M, Gonzalez Moreno, L, Garcia-Buey, L, Molina Baena, B, Sampedro-Nuñez, M, Beceiro, MJ, García-Monzón, C, González-Rodríguez, Á .

Potential protective role of let-7d-5p in atherosclerosis progression reducing the inflammatory pathway regulated by NF-κB and vascular smooth muscle cells proliferation.

Aroca-Esteban, J, Souza-Neto, FV, Aguilar-Latorre, C, Tribaldo-Torralbo, A, González-López, P, Ruiz-Simón, R, Álvarez-Villareal, M, Ballesteros, S, de Ceniga, MV, Landete, P, González-Rodríguez, Á , Martín-Ventura, JL, de Las Heras, N, Escribano, Ó, Gómez-Hernández, A.

Fibroblast growth factor 21 is a hepatokine involved in MASLD progression.

Gallego-Durán, R, Ampuero, J, Maya-Miles, D, Pastor-Ramírez, H, Montero-Vallejo, R, Rivera-Esteban, J, Álvarez-Amor, L, Pareja, MJ, Rico, MC, Millán, R, Robles-Frías, MJ, Aller, R, Rojas, Á, Muñoz-Hernández, R, Gil-Gómez, A, Gato, S, García-Lozano, M, Arias-Loste, MT, Abad, J, Calleja, JL, Andrade, RJ, Crespo, J, González-Rodríguez, Á , García-Monzón, C, Andreola, F, Pericás, JM, Jalan, R, Martín-Bermudo, F, Romero-Gómez, M.

Hospital-based screening outperforms primary care screening as a means of achieving hepatitis C virus micro-elimination.

Fernández-García, CE, Gallego-Galiana, J, Solís-Muñoz, PA, Del Pozo-Maroto, E, Domínguez-Alcón, L, Tobar-Izquierdo, M, Sáez, A, Rodríguez de Cía, J, Magaña-Sánchez, A, Real-Martínez, Y, García-Buey, L, González-Moreno, L, Caldas-Álvarez, M, Cardeñoso-Domingo, LM, González-Gamarra, A, Salvador-Calvo, A, González-Rodríguez, Á , García-Monzón, C.

Editorial: mitochondrial respiratory chain activity-a potential link with disease severity and treatment response in alcoholic hepatitis. Authors' reply.

Solís-Muñoz, P, de la Flor-Robledo, M, Fernández-García, CE, González-Rodríguez, Á , García-Monzón, C.

Mitochondrial respiratory chain activity is associated with severity, corticosteroid response and prognosis of alcoholic hepatitis.

Solís-Muñoz, P, de la Flor-Robledo, M, García-Ruíz, I, Fernández-García, CE, González-Rodríguez, Á , Shah, N, Bataller, R, Heneghan, M, García-Monzón, C, Solís-Herruzo, JA.

Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool.

Marañón, P, Fernández-García, CE, Isaza, SC, Rey, E, Gallego-Durán, R, Montero-Vallejo, R, de Cía, JR, Ampuero, J, Romero-Gómez, M, García-Monzón, C, González-Rodríguez, Á .

Involvement of G protein-coupled receptor kinase 2 (GRK2) in the development of non-alcoholic steatosis and steatohepatitis in mice and humans.

Cruces-Sande, M, Vila-Bedmar, R, Arcones, AC, González-Rodríguez, Á , Rada, P , Gutiérrez-de-Juan, V, Vargas-Castrillón, J, Iruzubieta, P, Sánchez-González, C, Formentini, L, Crespo, J, García-Monzón, C, Martínez-Chantar, ML, Valverde, ÁM , Mayor, F, Murga, C.

A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice.

Valdecantos, MP , Pardo, V , Ruiz, L , Castro-Sánchez, L, Lanzón, B, Fernández-Millán, E, García-Monzón, C, Arroba, AI , González-Rodríguez, Á , Escrivá, F, Álvarez, C, Rupérez, FJ, Barbas, C, Konkar, A, Naylor, J, Hornigold, D, Santos, AD, Bednarek, M, Grimsby, J, Rondinone, CM, Valverde, ÁM .

Dissecting the role of epidermal growth factor receptor catalytic activity during liver regeneration and hepatocarcinogenesis.

López-Luque, J, Caballero-Díaz, D, Martinez-Palacián, A, Roncero, C, Moreno-Càceres, J, García-Bravo, M, Grueso, E, Fernández, A, Crosas-Molist, E, García-Álvaro, M, Addante, A, Bertran, E, Valverde, AM , González-Rodríguez, Á , Herrera, B, Montoliu, L, Serrano, T, Segovia, JC, Fernández, M , Ramos, E, Sánchez, A, Fabregat, I.

C/ Arturo Duperier 4 | 28029 Madrid (España) | Teléfono +(34) 91 585 4400 | Código DIR3: E02764003